Resideo director granted 5,468 company shares
DENINGER PAUL F reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DENINGER PAUL F reported acquisition or exercise transactions in this Form 4 filing.
Resideo Technologies director Paul F. Deninger received a grant of 5,468 shares of Common Stock as compensation. The shares were awarded at no purchase price, reflecting a stock-based grant rather than an open-market transaction. Following this award, Deninger directly holds a total of 80,294 Resideo common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,468 | $0.00 | $0.00 |
Key Figures
Key Terms
Form 4 regulatory
Common Stock financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Resideo Technologies (REZI) report for Paul F. Deninger?
Was the Resideo (REZI) Form 4 transaction a market purchase or sale?
What does transaction code "A" mean in the Resideo (REZI) Form 4 for Paul F. Deninger?
Does the Resideo (REZI) Form 4 show any stock option exercises or derivative trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.